Cleared Traditional

K901875 - PARA 12 PLUS

K901875 is the FDA 510(k) clearance for PARA 12 PLUS by Streck Laboratories, Inc.. It is a Class 2 Hematology device (product code JCN) cleared through the Traditional 510(k) pathway after a 34-day FDA review.

K901875 · Streck Laboratories, Inc. · Hematology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 1990
Decision
34d
Days
Class 2
Risk

K901875 is an FDA 510(k) clearance for the PARA 12 PLUS. Classified as Control, Cell Counter, Normal And Abnormal (product code JCN), Class II - Special Controls.

Submitted by Streck Laboratories, Inc. (Omaha, US). The FDA issued a Cleared decision on May 30, 1990 after a review of 34 days - a notably fast clearance cycle.

This device falls under the Hematology FDA review panel, regulated under 21 CFR 864.8625 - the FDA hematology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Streck Laboratories, Inc. devices

Submission Details

510(k) Number K901875 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 26, 1990
Decision Date May 30, 1990
Days to Decision 34 days
Submission Type Traditional
Review Panel Hematology (HE)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
79d faster than avg
Panel avg: 113d · This submission: 34d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code JCN Control, Cell Counter, Normal And Abnormal
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 864.8625
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Hematology devices follow this clearance model.

Regulatory Peers - JCN Control, Cell Counter, Normal And Abnormal

All 8
Devices cleared under the same product code (JCN) and FDA review panel - the closest regulatory comparables to K901875.
CBC-STK(TM) HEMATOLOGY CONTROL/MULTIPLE
K934497 · R&D Systems, Inc. · Dec 1993
STAK-CHEX
K911582 · Streck Laboratories, Inc. · May 1991
CELL-DYN 3000 CONTROL
K902391 · Unipath , Ltd. · Aug 1990
PARA TECH FOR TECHNICON H-1
K896154 · Streck Laboratories, Inc. · Nov 1989
QBC(R) CENTRIFUGAL HEMATOLOGY CONTR/MULTI MODIFIED
K891907 · R&D Systems, Inc. · Apr 1989
CBC-TECH(TM) HEMATOLOGY CONTROL/MULTIPLE
K874386 · R&D Systems, Inc. · Dec 1987